France In Vitro Diagnostics Market
Description
Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Software), By Test Location (Point of Care, Home-care), By End-use (Hospitals, Laboratory), By Application, By Technology, And Segment Forecasts, 2026 - 2033
France In Vitro Diagnostics Market Summary
The France in vitro diagnostics market size was estimated at USD 4.37 billion in 2025 and is projected to reach USD 6.93 billion by 2030, growing at a CAGR of 5.86% from 2026 to 2033. Some of the key growth factors driving the market growth include the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and the shift toward value-based healthcare emphasizing early detection and preventive care.
The growth of the market is attributed to the rising global demand for accurate, rapid, and personalized diagnostic solutions. The integration of digital health, AI, and data analytics into diagnostic platforms enhances test accuracy and clinical decision-making. In addition, the expansion of point-of-care testing, personalized medicine, and emerging markets, coupled with heightened pandemic preparedness, continues to drive market penetration, creating significant opportunities for industry stakeholders.
The France in vitro diagnostics industry is evolving rapidly, driven by technological advancements, rising disease prevalence, and government initiatives to strengthen healthcare infrastructure. Major global players, including Roche, Thermo Fisher Scientific, Qiagen, Danaher, and Hologic, have established a strong presence in France, continuously expanding their molecular diagnostics portfolios with real-time PCR systems and high-throughput sequencing tools.
Furthermore, the French molecular diagnostic market would thus be directly impacted by this acquisition, as companies expand their capabilities and presence in this growing sector. In January 2025, bioMérieux acquired SpinChip Diagnostics ASA (SpinChip). This small benchtop analyzer is designed for near-patient testing, delivering high-sensitivity results from whole blood samples within 10 minutes-a level of performance previously available only in laboratory settings.
France In Vitro Diagnostics Market Report Segmentation
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the France in vitro diagnostics market report based on products, technology, application, test location, and end-use:
France In Vitro Diagnostics Market Summary
The France in vitro diagnostics market size was estimated at USD 4.37 billion in 2025 and is projected to reach USD 6.93 billion by 2030, growing at a CAGR of 5.86% from 2026 to 2033. Some of the key growth factors driving the market growth include the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and the shift toward value-based healthcare emphasizing early detection and preventive care.
The growth of the market is attributed to the rising global demand for accurate, rapid, and personalized diagnostic solutions. The integration of digital health, AI, and data analytics into diagnostic platforms enhances test accuracy and clinical decision-making. In addition, the expansion of point-of-care testing, personalized medicine, and emerging markets, coupled with heightened pandemic preparedness, continues to drive market penetration, creating significant opportunities for industry stakeholders.
The France in vitro diagnostics industry is evolving rapidly, driven by technological advancements, rising disease prevalence, and government initiatives to strengthen healthcare infrastructure. Major global players, including Roche, Thermo Fisher Scientific, Qiagen, Danaher, and Hologic, have established a strong presence in France, continuously expanding their molecular diagnostics portfolios with real-time PCR systems and high-throughput sequencing tools.
Furthermore, the French molecular diagnostic market would thus be directly impacted by this acquisition, as companies expand their capabilities and presence in this growing sector. In January 2025, bioMérieux acquired SpinChip Diagnostics ASA (SpinChip). This small benchtop analyzer is designed for near-patient testing, delivering high-sensitivity results from whole blood samples within 10 minutes-a level of performance previously available only in laboratory settings.
France In Vitro Diagnostics Market Report Segmentation
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the France in vitro diagnostics market report based on products, technology, application, test location, and end-use:
- Product Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
- Instruments
- Reagents
- Software
- Technology Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
- Immunoassay
- Instruments
- Reagents
- Others
- Hematology
- Instruments
- Reagents
- Others
- Clinical Chemistry
- Instruments
- Reagents
- Others
- Molecular Diagnostics
- Instruments
- Reagents
- Others
- Coagulation
- Instruments
- Reagents
- Others
- Microbiology
- Instruments
- Reagents
- Others
- Others
- Instruments
- Reagents
- Others
- Application Outlook (Revenue, USD Billion, 2021 - 2033)
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune Diseases
- Drug Testing
- Other applications
- Test Location Outlook (Revenue, USD Billion, 2021 - 2033)
- Point of Care
- Home-care
- Others
- End-use Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
- Hospitals
- Public
- Private
- Laboratory
- Public
- Private
- Others
Table of Contents
320 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Application
- 1.2.4. Test Location
- 1.2.5. End Use
- 1.3. Regional Scope
- 1.4. Estimates and Forecast Timeline
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR’s Internal Database
- 1.7. Details of primary research
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity flow analysis (Model 1)
- 1.9.1.1. Approach 1: Commodity flow approach
- 1.9.2. Volume price analysis (Model 2)
- 1.9.2.1. Approach 2: Volume price analysis
- 1.10. Research Scope and Assumptions
- 1.10.1. List of Secondary Sources
- 1.10.2. List of Primary Sources
- 1.10.3. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. France In Vitro Diagnostics Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. High public healthcare spending & strong per-capita health investment
- 3.2.1.2. Increased national lab capacity, testing awareness and volumes
- 3.2.1.3. Government support for innovative diagnostics
- 3.2.1.4. Improved validation and reimbursement pathways for new IVDs.
- 3.2.2. Market Restraints Analysis
- 3.2.2.1. Pricing pressure and tight cost containment measures
- 3.2.2.2. Regulatory complexity and IVDR-related burden
- 3.2.2.3. Limited volume growth for conventional IVD tests
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Supply Chain Analysis
- 3.2.5. Distribution Channel
- 3.2.5.1. Direct Sales
- 3.2.5.2. Distributors Network
- 3.2.5.3. E-commerce and Online Platforms
- 3.2.5.4. Major Distributors
- 3.3. France In Vitro Diagnostics Market Analysis Tools
- 3.3.1. Porter’s Analysis
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Legal landscape
- 3.4. Reimbursement Overview of IVDs and LDTs
- 3.5. Pricing Analysis
- Chapter 4. France In Vitro Diagnostics Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. France In Vitro Diagnostics Market: Product Movement Analysis, 2025 & 2033 (USD Billion)
- 4.3. Instruments
- 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.4. Reagents
- 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5. Services
- 4.5.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- Chapter 5. France In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. France In Vitro Diagnostics Market: Technology Movement Analysis, 2025 & 2033 (USD Billion)
- 5.3. Immunoassay
- 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.3.2. Instruments
- 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Units)
- 5.3.3. Reagents
- 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.3.4. Services
- 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.4. Hematology
- 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.4.2. Instruments
- 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.4.3. Reagents
- 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.4.4. Services
- 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.5. Clinical Chemistry
- 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.5.2. Instruments
- 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.5.3. Reagents
- 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.5.4. Services
- 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.6. Molecular Diagnostics
- 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.6.2. Instruments
- 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.6.3. Reagents
- 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.6.4. Services
- 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.7. Coagulation
- 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.7.2. Instruments
- 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.7.3. Reagents
- 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.7.4. Services
- 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.8. Microbiology
- 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.8.2. Instruments
- 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.8.3. Reagents
- 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.8.4. Services
- 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.9. Others
- 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.9.2. Instruments
- 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.9.3. Reagents
- 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.9.4. Services
- 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- Chapter 6. France In Vitro Diagnostics Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. France In Vitro Diagnostics Market: Application Movement Analysis, 2025 & 2033 (USD Billion)
- 6.3. Infectious Disease
- 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4. Diabetes
- 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.5. Oncology/Cancer
- 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.6. Cardiology
- 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.7. Nephrology
- 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.8. Autoimmune Diseases
- 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.9. Drug Testing
- 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.10. Others
- 6.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- Chapter 7. France In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. France In Vitro Diagnostics Market: Test Location Movement Analysis, 2025 & 2033 (USD Billion)
- 7.3. Point of Care
- 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 7.4. Home-care
- 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 7.5. Others
- 7.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
- Chapter 8. France In Vitro Diagnostics Market: End Use Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. France In Vitro Diagnostics Market: End Use Movement Analysis, 2025 & 2033 (USD Billion)
- 8.3. Hospitals
- 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 8.3.2. Private
- 8.3.2.1. Private Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 8.3.3. Public
- 8.3.3.1. Public Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 8.4. Laboratory
- 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 8.4.2. Private
- 8.4.2.1. Private Labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 8.4.3. Public
- 8.4.3.1. Public Labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 8.5. Others
- 8.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis by Key Market Participants
- 9.2. Company Categorization
- 9.3. Global and local Company Market Share Analysis, 2025
- 9.4. Company Heat Map Analysis
- 9.5. Strategy Mapping
- 9.5.1. Expansion
- 9.5.2. Mergers & Acquisition
- 9.5.3. Partnerships & Collaborations
- 9.5.4. New Product Launches
- 9.5.5. Research And Development
- 9.6. Company Profiles
- 9.6.1. Euroblo Scientific
- 9.6.1.1. Participant’s Overview
- 9.6.1.2. Financial Performance
- 9.6.1.3. Product Benchmarking
- 9.6.1.4. Recent Developments
- 9.6.2. Servibio
- 9.6.2.1. Participant’s Overview
- 9.6.2.2. Financial Performance
- 9.6.2.3. Product Benchmarking
- 9.6.2.4. Recent Developments
- 9.6.3. CliniSciences
- 9.6.3.1. Participant’s Overview
- 9.6.3.2. Financial Performance
- 9.6.3.3. Product Benchmarking
- 9.6.3.4. Recent Developments
- 9.6.4. Avantor, Inc.
- 9.6.4.1. Participant’s Overview
- 9.6.4.2. Financial Performance
- 9.6.4.3. Product Benchmarking
- 9.6.4.4. Recent Developments
- 9.6.5. QIAGEN
- 9.6.5.1. Participant’s Overview
- 9.6.5.2. Financial Performance
- 9.6.5.3. Product Benchmarking
- 9.6.5.4. Recent Developments
- 9.6.6. BD
- 9.6.6.1. Participant’s Overview
- 9.6.6.2. Financial Performance
- 9.6.6.3. Product Benchmarking
- 9.6.6.4. Recent Developments
- 9.6.7. bioMerieux SA
- 9.6.7.1. Participant’s Overview
- 9.6.7.2. Financial Performance
- 9.6.7.3. Product Benchmarking
- 9.6.7.4. Recent Developments
- 9.6.8. F. Hoffmann-La Roche Ltd.
- 9.6.8.1. Participant’s Overview
- 9.6.8.2. Financial Performance
- 9.6.8.3. Product Benchmarking
- 9.6.8.4. Recent Developments
- 9.6.9. QuidelOrtho Corporation
- 9.6.9.1. Participant’s Overview
- 9.6.9.2. Financial Performance
- 9.6.9.3. Product Benchmarking
- 9.6.9.4. Recent Developments
- 9.6.10. Abbott
- 9.6.10.1. Participant’s Overview
- 9.6.10.2. Financial Performance
- 9.6.10.3. Product Benchmarking
- 9.6.10.4. Recent Developments
- 9.6.11. Agilent Technologies, Inc.
- 9.6.11.1. Participant’s Overview
- 9.6.11.2. Financial Performance
- 9.6.11.3. Product Benchmarking
- 9.6.11.4. Recent Developments
- 9.6.12. Siemens Healthineers AG
- 9.6.12.1. Participant’s Overview
- 9.6.12.2. Financial Performance
- 9.6.12.3. Product Benchmarking
- 9.6.12.4. Recent Developments
- 9.6.13. Bio-Rad Laboratories, Inc.
- 9.6.13.1. Participant’s Overview
- 9.6.13.2. Financial Performance
- 9.6.13.3. Product Benchmarking
- 9.6.13.4. Recent Developments
- 9.6.14. Danaher
- 9.6.14.1. Participant’s Overview
- 9.6.14.2. Financial Performance
- 9.6.14.3. Product Benchmarking
- 9.6.14.4. Recent Developments
- 9.6.15. Sysmex Corporation
- 9.6.15.1. Participant’s Overview
- 9.6.15.2. Financial Performance
- 9.6.15.3. Product Benchmarking
- 9.6.15.4. Recent Developments
- 9.6.16. Charles River Laboratories
- 9.6.16.1. Participant’s Overview
- 9.6.16.2. Financial Performance
- 9.6.16.3. Product Benchmarking
- 9.6.16.4. Recent Developments
- 9.6.17. Quest Diagnostics Incorporated
- 9.6.17.1. Participant’s Overview
- 9.6.17.2. Financial Performance
- 9.6.17.3. Product Benchmarking
- 9.6.17.4. Recent Developments
- 9.6.18. Novacyt Group
- 9.6.18.1. Participant’s Overview
- 9.6.18.2. Financial Performance
- 9.6.18.3. Product Benchmarking
- 9.6.18.4. Recent Developments
- 9.6.19. Acobiom
- 9.6.19.1. Participant’s Overview
- 9.6.19.2. Financial Performance
- 9.6.19.3. Product Benchmarking
- 9.6.19.4. Recent Developments
- 9.6.20. Poly-Dtech
- 9.6.20.1. Participant’s Overview
- 9.6.20.2. Financial Performance
- 9.6.20.3. Product Benchmarking
- 9.6.20.4. Recent Developments
- 9.6.21. Biosynex.
- 9.6.21.1. Participant’s Overview
- 9.6.21.2. Financial Performance
- 9.6.21.3. Product Benchmarking
- 9.6.21.4. Recent Developments
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
